The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Regorafenib second-line therapy for surgical recurrent hepatocellular carcinoma: An exploration of continuing regorafenib therapy after tumor progression—A single-center retrospective analysis of 90 cases.
 
Liqun Wu
No Relationships to Disclose
 
Wei Rao
No Relationships to Disclose
 
Ge Guan
No Relationships to Disclose
 
Yang Xin
No Relationships to Disclose
 
Qinghui Niu
No Relationships to Disclose
 
Ning Fan
No Relationships to Disclose
 
Yuan Guo
No Relationships to Disclose
 
Zixiang Li
No Relationships to Disclose
 
Song Wang
No Relationships to Disclose
 
Jinzhen Cai
No Relationships to Disclose